QSR - Why Is Soligenix (SNGX) Stock Down 35% Today?
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Soligenix (NASDAQ:SNGX) stock is falling hard on Tuesday after the company’s HyBryte cancer drug was rejected by the FDA.
The FDA is refusing to review an application for Soligenix covering a rare type of cancer drug. Its reason is the company’s application not being sufficiently complete to facilitate a substantive review.
According to a press release, Soligenix is seeking guidance from the FDA following its rejection. The company wants to further advance HyBryte and needs the FDA’s help in learning what needs to be done next.
HyBryte is a drug in development to treat early-stage cutaneous T-cell lymphoma. This is a rare form of cancer that starts in white blood cells and attacks the skin. The company filed a marketing application for the drug in December.
How SNGX Stock Is Reacting
Today’s rejection brings with it heavy trading of SNGX stock. As of this writing, more than 427,000 shares of the stock have changed hands. That’s well above the company’s daily average trading volume of about 8,000 shares as investors sell the stock.
SNGX stock is down 27.2% as of Tuesday morning and is down 41.4% since the start of the year.
Investors seeking out more of the latest stock market news will want to keep reading!
InvestorPlace is home to all of the hottest stock market news traders need to know about on Tuesday! That includes why shares of Restaurant Brands (NYSE:QSR), Amesite (NASDAQ:AMST), and Tesla (NASDAQ:TSLA) stock are on the move today. You can learn more about these matters at the following links!
More Tuesday Stock Market News
- QSR Stock: What to Know About Restaurant Brands’ New CEO
- Why Is Amesite (AMST) Stock Up 100% Today?
- Is Tesla (TSLA) Stock Getting Ready for a ‘Massacre’?
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
More From InvestorPlace
- Buy This $5 Stock BEFORE This Apple Project Goes Live
- The Best $1 Investment You Can Make Today
- It doesn’t matter if you have $500 or $5 million. Do this now.
- Massive Bear Market “Divergence Event” Ahead… And The #1 Way to Play It
The post Why Is Soligenix (SNGX) Stock Down 35% Today? appeared first on InvestorPlace.